Navigation Links
Makers of OTC Cough Medicines Reaffirm Efficacy of Products
Date:1/22/2008

Cochrane report provides no elements of new data

WASHINGTON, Jan. 22 /PRNewswire-USNewswire/ -- Today, the international Cochrane Collaboration released a review of existing data on the efficacy of oral over-the-counter (OTC) cough medicines in children and adults. While this review includes a limited number of OTC medicines available in the U.S., the majority of studies show statistically significant improvement in adult populations.

The Consumer Healthcare Products Association (CHPA), representing the leading makers of OTC cough medicine in the U.S., stands behind the efficacy of these medicines, citing a number of well-designed clinical studies showing that acute cough sufferers receive beneficial relief from these medicines. "Consumers should continue to remain confident that their OTC cough remedies provide the same symptomatic relief as in past cold seasons," explained Heinz Schneider, Dr. Med., CHPA's vice president, Regulatory & Scientific Affairs. "As the authors of this review indicate, common cold research is challenging--especially in younger populations. CHPA has presented positive efficacy data in adults to the U.S. Food and Drug Administration (FDA) and has already begun to work with experts and FDA on methodologies for further research on the effects of medicines on common cold symptoms in children."

Additionally, as Dr. Schneider notes, consumers report finding relief through OTC cough remedies, "According to a recent survey, 89% of adults, parents and caregivers say the OTC cough remedies they used effectively helped them or the child in their household cough less. And, more than three-quarters of adults, parents, and caregivers also indicate that OTC cough remedies helped them and the child both function and sleep better."

Editor's Note: Frequently Asked Questions on cough medicine are available at http://www.c
'/>"/>

SOURCE Consumer Healthcare Products Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Susan G. Komen for the Cure, State Lawmakers, Breast Cancer Survivors, Celebrities and Activists Call on Legislature to Strengthen Breast Cancer Screening Program for Underserved Women
2. AARP CEO Bill Novelli Tells Lawmakers: Controlling Health Care Costs Key to Budget Reform
3. Decision-makers seek internal balance, not balanced alternatives
4. Susan G. Komen For The Cure, Karmanos Cancer Institute, Local Hospitals Call on Policymakers to Address Injustice and Unfairness in Breast Cancer Incidence and Mortality
5. 273 Lawmakers Put Kids First
6. U.S. Medical Schools, Drug Makers Share Strong Ties
7. Drug Makers Withdraw Cough, Cold Meds for Infants
8. Makers of OTC Cough and Cold Medicines Announce Voluntary Withdrawal of Oral Infant Medicines
9. Hospitals and the Coalition to Protect Floridas Drivers Applaud Lawmakers for Reviving No-Fault Insurance
10. Equipping your Sales Force to Influence Hospital Formulary Decision-Makers
11. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... The Arthritis Foundation bes...erving recipients during its national meeting in A...r 3, 2009 -- The Arthritis Foundation bestowed its...cipients during its national meeting on Nov. 20 in...es B. Harding Award for Distinguished Service ,The...
(Date:12/3/2009)... A quick and easy way to keep...d touch. Pop up menu’s and one touch exporti...nap. A great tool for the busy medical provider. ... -- I-Surgery , a new iPhone application for surg...interns, medical students, and PA’s. Just a...
(Date:12/3/2009)... The Lifestyle Advisors at Vi...Gifts to ease the stress of finding that perfect g...he DIY treatments in health, fitness and wellness ... on time and within budget. , ...on mySpaShop (mSS), has gathered an assortment o...
(Date:12/3/2009)... Carlton Scott RN, hopes to c...-published and illustrated books, “Little Bi...quo; Proceeds from the sales will go to children&r... (PRWEB) December 3, 2009 -- Carlton Scott ...onwide with his self-published and self-illustrate...
(Date:12/3/2009)... A revolutionary device that ...where, is now available. , ...ss news channels, web sites and magazine covers da...es about the spread of H1N1 influenza A (swine flu...or clinics paint a discouraging picture during thi...
Breaking Medicine News(10 mins):Health News:Arthritis Foundation Bestows Highest National Awards 2Health News:Arthritis Foundation Bestows Highest National Awards 3Health News:Arthritis Foundation Bestows Highest National Awards 4Health News:Bring Spa Home for the Holidays at mySpaShop & Celebrate Recipes for Personal Spa Treatments 2Health News:Bring Spa Home for the Holidays at mySpaShop & Celebrate Recipes for Personal Spa Treatments 3Health News:Bring Spa Home for the Holidays at mySpaShop & Celebrate Recipes for Personal Spa Treatments 4Health News:Traveling Nurse Cheers up Kids with Handmade Books 2Health News:Traveling Nurse Cheers up Kids with Handmade Books 3Health News:Finally, Some Good News about Swine Flu 2
...e Housing as a Major Cause, LOS ANGELES, Nov. 14 ...omelessness is no longer an isolated phenomenon re.... In fact, according to the,survey released this m...ive who would have otherwise become homeless. One ...
...hat delivers,insights into improving an organizati...nufacturing and online financial services -- is no...ne research repository managed by,research and con...is address:, http://www3.best-in-class.com/de467.h...
...day with the U.S. Food and Drug Administration, an... seeks to compel the agency to stem the flood of d...ating the use of scientifically superior non-anima...oposed settlement with Merck because she is concer...
...pt,Pharmaceuticals, Inc. today announced that Thom...ancial Officer, will present at the 19th Annual,Pi...otel in New York City,on Tuesday, November 27, 200...nt new patient benefits from proven CNS drugs. Tra...
... dying of cancer, Dr. Jack Stephens, and Pets Bes...ultations with a cancer specialist...tephens, DVM, founder,and president of Pets Best I...one in every two dogs and cats who are 10,years or...
... doses of freeze-dried grape powder inhibit genes ...ancer, University of California, Irvine cancer res...rich in grapes may help prevent the third most com...g their lifetimes. , Led by Dr. Randall Holcombe,...
Other Medicine News:Health News:New Gallup Survey Finds Half of Los Angeles Area Residents Have Taken in a Near-Homeless Person, One-Third Fear Homelessness Themselves 2Health News:New Gallup Survey Finds Half of Los Angeles Area Residents Have Taken in a Near-Homeless Person, One-Third Fear Homelessness Themselves 3Health News:Best Practice Database Adds New Research on New Product Launches, Online Financial Services and Manufacturing Operations 2Health News:FDA petition would protect public from dangerous drugs 2Health News:All Pets With Cancer in U.S. Provided Free Consultation 2Health News:All Pets With Cancer in U.S. Provided Free Consultation 3Health News:All Pets With Cancer in U.S. Provided Free Consultation 4Health News:Grape powder blocks genes linked to colon cancer 2Health News:Grape powder blocks genes linked to colon cancer 3
(Date:12/2/2009)...ALTO, Calif., Dec. 2 Var...ber 25, 2009, Varian, Inc. filed with the U.S. Sec...on Form 10-K for the fiscal year ended October 2, ...the Company,s web site at www.varianinc.com, by cl...on "10-K" in the table shown. Stockholders may re...
(Date:12/2/2009)...NEW YORK, Dec. 2 Reportlinker.com ...ilable in its catalogue: ,, Chiral Technology ..., http://www.reportlinker.com/p0164212/Chiral-T...s.html ,, The fast developing small molecule ... activity with pharmaceutical companies adding chi...
(Date:12/2/2009)...EW YORK, Dec. 2 Reportlinker.com a...lable in its catalogue: ,, Multiple Myeloma T..., http://www.reportlinker.com/p0164271/Multiple....html ,, Given the severity, and relentless re...nt therapies and treatments to battle the disease ...
Breaking Medicine Technology:Reportlinker Adds Chiral Technology - International Technology & Market Trends 2Reportlinker Adds Chiral Technology - International Technology & Market Trends 3Reportlinker Adds Chiral Technology - International Technology & Market Trends 4Reportlinker Adds Chiral Technology - International Technology & Market Trends 5Reportlinker Adds Multiple Myeloma Therapeutics - US Market Trends & Analysis 2Reportlinker Adds Multiple Myeloma Therapeutics - US Market Trends & Analysis 3Reportlinker Adds Multiple Myeloma Therapeutics - US Market Trends & Analysis 4Reportlinker Adds Multiple Myeloma Therapeutics - US Market Trends & Analysis 5Reportlinker Adds Multiple Myeloma Therapeutics - US Market Trends & Analysis 6Global AIDS Alliance Calls on President Obama to Honor His Campaign Promises on Global AIDS and Education 51117 1Global AIDS Alliance Calls on President Obama to Honor His Campaign Promises on Global AIDS and Education 51117 2Global AIDS Alliance Calls on President Obama to Honor His Campaign Promises on Global AIDS and Education 51117 3Screen All Newborns for Hip Dysplasia Study Urges 51115 1Screen All Newborns for Hip Dysplasia Study Urges 51115 2Experts Keep Wary Eye on Tamiflu Resistant Swine Flu 51113 1Experts Keep Wary Eye on Tamiflu Resistant Swine Flu 51113 2Experts Keep Wary Eye on Tamiflu Resistant Swine Flu 51113 3
...atients May Be Amenable to Chaperone ...13 Amicus Therapeutics, a,biopharmaceutical compa...pharmacological chaperones for the treatment of hu...any will present positive results from an ex,vivo ... (1-deoxynojirimycin,HCl), Amicus, compound in dev...
...ch 13 Raven,biotechnologies, inc., a privately he...t of monoclonal antibody therapeutics (MAbs) for c...e 2 study of RAV12, its lead,clinical product, in ...atients with metastatic pancreatic cancer., The P...t approximately,20 institutions in the US. The fir...
Other Medicine Technology:Amicus Therapeutics Presents Data from Clinical Ex Vivo Response Study and Phase 1 Studies of AT2220 2Amicus Therapeutics Presents Data from Clinical Ex Vivo Response Study and Phase 1 Studies of AT2220 3Amicus Therapeutics Presents Data from Clinical Ex Vivo Response Study and Phase 1 Studies of AT2220 4Raven Announces Initiation of a RAV12 Phase 2 Clinical Trial in Metastatic Pancreatic Cancer 2Raven Announces Initiation of a RAV12 Phase 2 Clinical Trial in Metastatic Pancreatic Cancer 3
Micro Slide Files
Unit System Slide Cabinet
Shandon Stackable Slide Storage Cabinet
Shandon Slide and Paraffin Block Cabinets
Medicine Products: